Microbial Fermentation Technology Market Size & Share, by Application (Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules); End-User (Bio-Pharmaceutical Companies, Contract Research Organizations (CROs), CMOs & CDMOs, Academic & Research Institutes); Type (Medical, Industrial, Alcohol Beverages, Food and Feed Products) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5329
  • Published Date: Oct 18, 2023
  • Report Format: PDF, PPT

Companies Dominating the Microbial Fermentation Technology Landscape

    • Biocon Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BioVectra Inc.
    • Danone UK
    • F. Hoffmann-La Roche AG
    • Koninklijke DSM NV
    • Lonza
    • Novozymes A/S
    • TerraVia Holdings, Inc.
    • Royal DSM

Browse Key Market Insights with Data Illustration:


In The News

  • BioVectra Inc. announced to diversification of manufacturing Capacity with Single-Use Microbial Fermentation Technology to support even more potential biologics for technology transfer and optimization, and offer enhanced flexibility, faster turnaround times, and increased capacity utilization to the customers. Furthermore, single-use sterile fermenters are intended to offer mixing, oxygen transmission, and cooling and provide a unique option and a significant benefit over stainless-steel fermenters in terms of batch segregation and cross-contamination hazards.
  • Danone UK partnered with Chr Hansen to push for innovation in both dairy and plant-based products and supply its 1800 strains of ferments to further research on the gut microbiome to focus on customer health and improve sustainability by reducing greenhouse gas emissions in its supply chain

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5329
  • Published Date: Oct 18, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rising need for vaccines and the growing need for microbial contract manufacturing services are the major factors driving the growth of the market.

The market size of Microbial Fermentation Technology is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market are BioVectra Inc., Danone UK, F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza, Novozymes A/S, TerraVia Holdings, Inc., BIOZEEN

The antibiotics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying